Technion-Israel Institute of Technology
It is essentially an electronic skin capable of recognizing the range of movement human joints make, with up to half a degree of precision.
Disposable utensils account for 9 percent of waste on campus; the move is intended to reduce such waste and lessen expenses.
An innovation for its prowess is the Machine Learning and Intelligent Systems research center, which aggregates all AI-related activities.
The joint student venture is the culmination of a faculty-wide process striving to balance two fields: aeronautics and outer space.
Technion biomedical engineering student Aseel Nama grew up in the Arab town of Deir al-Asad in the Galilee and is now based in Haifa.
“This breakthrough reflects an artistic expression of the scientific expertise of our team,” says Didier Toubia, co-founder and CEO of Aleph Farms.
Study: Even one dose of Pfizer COVID-19 vaccine lowers viral load and spread
New Israeli research bolsters emerging evidence that Pfizer-BioNTech’s vaccine protects both those immunized and those around them.
Technion to award Pfizer CEO honorary doctorate for coronavirus vaccine
“This is an emotional closure for me,” says Albert Bourla, the son of Holocaust survivors from Thessaloniki.
Breakthrough in research could influence treatment of leukemia spreading to brain
The discovery is relevant for several other types of cancer in children and adults since most mortalities are not caused by the primary tumor. but by the spread of metastasized cells to distant organs.
Developments from the faculty of mechanical engineering at the Technion show innovation in light amplification: 10,000,000 rotations that pass through a cross-sectional area of about a micron squared, increasing the light 10 million times.
Staff members are at the forefront of medical technologies and innovation, task forces, methods and vaccines in the making, working to protect the spread of the COVID-19 virus.
Israeli researchers announce new, faster testing method for COVID-19
The new method, called pooling, allows for the simultaneous testing of some 60 patients, which should “greatly increase” the rate at which infections are identified.